Authors: Waldmeier, PC Spooren, WPJM Hengerer, B

Citation: Pc. Waldmeier et al., CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease, N-S ARCH PH, 362(6), 2000, pp. 526-537

Authors: Heumann, R Goemans, C Bartsch, D Lingenhohl, K Waldmeier, PC Hengerer, B Allegrini, PR Schellander, K Wagner, EF Arendt, T Kamdem, RH Obst-Pernberg, K Narz, F Wahle, P Berns, H

Citation: R. Heumann et al., Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration, J CELL BIOL, 151(7), 2000, pp. 1537-1548

Authors: Sagot, Y Toni, N Perrelet, D Lurot, S King, B Rixner, H Mattenberger, L Waldmeier, PC Kato, AC

Citation: Y. Sagot et al., An orally active anti-apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease, BR J PHARM, 131(4), 2000, pp. 721-728

Authors: Zimmermann, K Waldmeier, PC Tatton, WG

Citation: K. Zimmermann et al., Dibenzoxepines as treatments for neurodegenerative diseases, PUR A CHEM, 71(11), 1999, pp. 2039-2046

Authors: Ong, J Kerr, DIB Bittiger, H Waldmeier, PC Baumann, PA Cooke, NG Mickel, SJ Froestl, W

Citation: J. Ong et al., Morpholin-2-yl-phosphinic acids are potent GABA(B) receptor antagonists inrat brain, EUR J PHARM, 362(1), 1998, pp. 27-34